Work

Making a case “for” focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials

Year: 2021

Type: article

Source: World Journal of Urology

DOI: 10.1007/s00345-020-03525-0

Authors: Alex Z. Wang, Amir H. Lebastchi, Luke P. O’Connor, Michael Ahdoot, Sherif Mehralivand, Nitin Yerram, Samir S. Taneja, Arvin K. George, Rafael Sanchez-Salas, John F. Ward, Pilar Laguna, Jean de la Rosette, Peter A. Pinto

Institutions: National Institutes of Health, National Cancer Institute, NYU Langone Health, New York University, Michigan Medicine, Institute Mutualiste Montsouris, Université Paris Descartes, The University of Texas MD Anderson Cancer Center, Istanbul Medipol University

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3118596182

FWCI: 1.621

Cites: 61

Cited by: 11

Related to: 10